Development of LNA gapmers, antisense oligonucleotides used for efficient inhibition of target RNA expression, is limited by non-target mediated hepatotoxicity issues. In the present study, we investigated hepatic transcription profiles of mice administered non-toxic and toxic LNA gapmers. After repeated administration, a toxic LNA gapmer (TS-2), but not a non-toxic LNA gapmer (NTS-1), caused hepatocyte necrosis and increased serum alanine aminotransferase levels. Microarray data revealed that, in addition to gene expression patterns consistent with hepatotoxicity, 17 genes in the clathrin-mediated endocytosis (CME) pathway were altered in the TS-2 group. TS-2 significantly down-regulated myosin 1E (Myo1E), which is involved in release of clathrin-coated pits from plasma membranes. To map the earliest transcription changes associated with LNA gapmer-induced hepatotoxicity, a second microarray analysis was performed using NTS-1, TS-2, and a severely toxic LNA gapmer (HTS-3) at 8, 16, and 72 h following a single administration in mice. The only histopathological change observed was minor hepatic hypertrophy in all LNA groups across time points. NTS-1, but not 2 toxic LNA gapmers, increased immune response genes at 8 and 16 h but not at 72 h. TS-2 significantly perturbed the CME pathway only at 72 h, while Myo1E levels were decreased at all time points. In contrast, HTS-3 modulated DNA damage pathway genes at 8 and 16 h and also modulated the CME pathway genes (but not Myo1E) at 16 h. Our results may suggest that different LNAs modulate distinct transcriptional genes and pathways contributing to non-target mediated hepatotoxicity in mice.
In preclinical studies, many LNA-modified ASOs caused significant hepatotoxicity in mice (Swayze et al., 2007; Burdick, Sciabola, Mantena, Hollingshead, Stanton, Warneke, Zeng, Martsen, Medvedev, Makarov, Reed, Davis II, and Whiteley) . Because a control LNA gapmer, which did not modulate target mRNA reduction, also induced hepatotoxicity in mice, the toxicity was considered to be independent of target (Swayze et al., 2007) . Replacement of a single nucleotide in the LNA gapmer sequences can have profound effects on its toxicity profile transforming a highly toxic compound to one that demonstrates only mild hepatotoxicity and vice versa (Stanton et al., 2012; Burdick, Sciabola, Mantena, Hollingshead, Stanton, Warneke, Zeng, Martsen, Medvedev, Makarov, Reed, Davis II, and Whiteley) .
Endocytosis is a process for the transfer of macromolecules into the cell across the plasma membrane (Conner and Schmid, 2003) . In higher eukaryotic cells, clathrin-dependent endocytosis is the important pathway for the uptake of molecules (nutrients, pathogens, antigens, and signaling molecules) (Conner and Schmid, 2003; Le Roy and Wrana, 2005; McMahon and Boucrot, 2011; Ungewickell and Hinrichsen, 2007) . Clathrin does not bind directly to the membrane or to cargo receptors, instead relying on other proteins such as adaptor proteins (eg, AP2) to be recruited to the plasma membrane (McMahon and Boucrot, 2011) . The dynamin ring is formed at the neck of the clathrin-coated pit (McMahon and Boucrot, 2011; Ungewickell and Hinrichsen, 2007) . Myo1E, shown to bind to the dynamin ring, pulls the dynamin ring toward the plasma membrane, resulting in scission and release of the clathrin-coated pit into the cytoplasm (Cheng et al., 2012; Ungewickell and Hinrichsen, 2007) . Cytoplasmic clathrin-coated vesicles are uncoated and then fuse with the early endosome expressing early endosome antigen 1 (EEA1). Early endosomes control the destination of internalized molecules (Le Roy and Wrana, 2005) , where they are sorted either back to the surface of cells for recycling or into other compartments (i.e., lysosomes, expressing LAMP1) for degradation (McMahon and Boucrot, 2011) . Caveolindependent endocytosis and clathrin-and caveloin-independent pathways are also present on many cells (Conner and Schmid, 2003) . Recently, it was demonstrated that the functional uptake of ASOs with 2′-MOE modification and a phosphorothioate backbone was blocked by siRNA inhibitors of AP2M1 but not clathrin or caveolin and appear to be mediated by a clathrin-and caveolin-independent endocytotic process (Koller et al., 2011) .
Here, we investigated the transcription profiles of liver RNA isolated from mice receiving different sequences of LNA gapmers at 2 weeks after repeated administration or 8, 16, and 72 h after a single administration. Using microarray analysis, our goal was to understand the mechanism of LNA gapmerinduced heptotoxicity in mice. The transcription profiling data were analyzed using Pfizer's Causal Reasoning Engine (CRE), which generates hypotheses information (including directionality) about the molecular upstream causes of the observed microarray data (Chindelevitch et al., 2012; Enayetallah et al., 2011 Enayetallah et al., , 2013 , and Ingenuity Pathway Analysis Software (IPA, http://www.ingenuity.com/) to elucidate pathways potentially contributing to hepatotoxicity.
MATERIALS AND METHODS
Synthesis of LNA gapmers and their sequences. The LNA-modified ASOs (3LNAs-8DNAs-3LNAs gapmer design) with phosphorothioated backbone were purchased from BioSpring. The sequences of LNA gapmers used in the study are shown below. Uppercase and lowercase indicate LNA and DNA residues, respectively.
Non-toxic sequence-1 (NTS-1, 2-week study and early time course study): 5′-TAAtcgtcgatACC-3′
Toxic sequence-2 (TS-2, 2-week study and early time course study): 5′-TAAtgctcgatCCC-3′
Highly toxic sequence-3 (HTS-3, early time course study only): 5′-TCAgtgcatccTTG-3′
NTS-1 and TS-2 are scrambled sequences and constructed not to target specific genes in mice. HTS-3 is constructed to target apolipoprotein C3 (ApoC3) in humans but not in mice.
Animal studies. All animal experiments were conducted under animal use protocols approved by Pfizer's Institutional Animal Care and Use Committee in compliance with the Guide for Care and Use of Laboratory Animals, and all applicable federal regulations.
Male CD-1 mice, 6 to 8-week-old at the study initiation, were obtained from Charles River Laboratories. Animals were acclimated to the laboratory environment for a minimum of 3 days prior to initiation of dosing. All mice were housed under standard conditions with a 12-hour light/dark cycle and free access to Purina 5002 Certified Rodent Diet (PMI Nutrition International) and water.
All LNA gapmers were dissolved in Dulbecco's phosphate buffered saline (DPBS, Lonza). Animals were allocated to study groups using a computerassisted randomization procedure based on body weights. In the 2-week study, animals were administered vehicle (DPBS) (10 mice), NTS-1 (5 mice), or TS-2 (5 mice) at 25 mg/kg (dose volume of 10 ml/kg) by subcutaneous injection once on day 1, 4, 8, and 11. Seventy-two hours after the final injection on day 11, mice were euthanized by exsanguination under gas isoflurane anesthesia. In the early time course study, mice (10 mice/group at each time point) were administered vehicle (DPBS), NTS-1, TS-2, or HTS-3 at 25 mg/kg (dose volume of 10 ml/kg) by subcutaneous injection once on day 1. Eight, 16, and 72 h after a single injection, mice were euthanized for necropsy. In both studies, blood was collected via the vena cava prior to necropsy for determining clinical chemistry parameters, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and glutamate dehydrogenase (GLDH) levels. The liver was collected, and representative samples were fixed in 10% buffered formalin, processed to paraffin block, sectioned (4 µm) and stained with hematoxylin and eosin for histopathological examination. In the 2-week study, all the remaining liver tissue was fresh frozen and stored at −80°C. In the early time course study, liver samples (approximately 25-50 mg each) were transferred to a tube containing RNAlater (Ambion), refrigerated overnight, and then frozen at −80°C; all remaining liver was also flash frozen and stored at −80°C. Blood and liver samples from the HTS-3 group were only collected at 8 and 16 h; the 72 h time point was not available since all mice at the 72 h time point in the HTS-3 group were found dead or sacrificed due to moribund conditions on day 3 (at least 48 h post administration).
RNA isolation and microarray experiments. All samples from the 2-week study and, 3 or 4 samples with the highest-ranking severity of minor hepatic hypertrophy score at each time point from the early time course study were selected for RNA isolation and subsequent gene expression analysis. RNA was isolated from fresh frozen (2-week study) and RNAlater-preserved (early time course study) liver using the Qiagen RNeasy Mini Plus Kit (Qiagen) according to the manufacturer's instructions. Sample quality was assessed by NanoDrop and Agilent Bioanalyzer for sample concentration, purity, and integrity (RIN), and all samples passed the quality control criteria immediately after RNA extraction and prior to preparing labeled target antisense RNA (cRNA). RNA samples were converted into cRNA using the Single-Round RNA Amplification and Biotin Labeling System (Enzo) according to the manufacturer's instructions. Purified cRNA was fragmented using a 5× fragmentation buffer, then a hybridization cocktail was prepared and added to the fragmentation product using the Hybridization, Wash and Stain kit (Affymetrix), applied to GeneChip Mouse Genome 430 2.0 Arrays (Affymetrix) at the appropriate volume and concentration, and incubated at 45°C for 16 h. Following hybridization, arrays were washed and stained using standard Affymetrix procedures before scanning on the Affymetrix GeneChip Scanner and data extraction using Expression Console.
Gene expression data analysis. Robust microarray analysis (RMA) background correction and quartile normalization were performed utilizing an internal Microarray Data Analysis System (MiDAS) (GEO: GSE53230). All RNA samples utilized for transcriptomic data generation had RIN values >7.0 and passed quality control thresholds. Prior to analysis of differentially expressed genes (DEGs), cRNA integrity was assessed by calculating specific 3′-5′ signal intensity ratios for beta-actin and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) probe sets and visualized to identify outlier samples by principal component analysis (PCA). Samples that had a 3′-5′ signal intensity ratio for GAPDH >1.7 showing a large separation from their cohorts on PCA plots were removed due to poor cRNA and/or gene chip quality. These included one sample in the NTS-1 group in the 2-week study and three samples (one each in the NTS-1 group at 8 h, the TS-2 group at 16 h, and the HTS-3 at 8 h) in the early time course study. Specific contrasts of interest were evaluated to generate raw p-values for each probe set on the expression array. The Benjamini-Hochberg false discovery rate method was then used to correct for multiple testing effects. Probe sets were considered to have changed qualitatively in a specific comparison if an adjusted p-value <.05 was obtained and they had an absolute fold change greater than 2.0 in the 2-week study. In the early time course study, using the same criteria, the number of DEGs at 8, 16, and 72 h was 128, 25, and 0 in the NTS-1 group, 4, 2, and 23 in the TS-2 group, and 56 (8 h) and 912 (16 h) in the HTS-3 group, respectively. One of our objectives in this study was to capture the earliest transcriptional changes associated with LNA gapmerinduced hepatotoxicity by comparing transcription changes induced by TS-2 at early time points to the 2-week study. For the earliest time point (i.e., 8 h), we could not exclude the possibility that genes with slight changes (i.e., fold change of <2) were biologically important and related to LNA-induced hepatotoxicity. Therefore, a less stringent criteria of fold change (>1.3) but the same adjusted p-value (<.05) was used. The number of DEGs at 8, 16, and 72 h was 133, 29 and 0 in the NTS-1 group, 13, 3, and 33 in the TS-2 group, and 112 (8 h) and 1749 (16 h) in the HTS-3 group, respectively (Table 3) .
DEGs were then analyzed using Pfizer's Causal Reasoning Engine (CRE) (Chindelevitch et al., 2012) . The CRE platform analyzes large scale experimental data, such as Affymetrix microarray data, in the context of prior biological knowledge to generate hypotheses about the molecular upstream causes of the observed data. The method relies upon an underlying knowledgebase of causal relationships manually curated from the literature, for example, "In MCF7 cells, HMGA1 protein increases expression of KITLG protein." The knowledgebase utilized in this work consists of approximately 500,000 relationships extracted from more than 125,000 biomedical articles. It covers findings from human, mouse, and rat experiments and a wide range of different cell and tissue types. The basic concept of Causal Reasoning has been applied successfully to elucidate the mode of action of compounds, as well as investigating in-vitro to in-vivo translatability and generating mechanistic hypotheses for adverse events based on molecular profiling data (Enayetallah et al., 2011 (Enayetallah et al., , 2013 Laifenfeld et al., 2010) . DEGs were also analyzed using Ingenuity Pathway Analysis Software (IPA, http://www.ingenuity.com/) to generate networks of interacting genes and identify signaling pathways and other functional groups.
Validation of microarray results (quantitative real-time PCR).
Complimentary DNA (cDNA) was produced by reverse transcription from total liver RNA isolated from mice using a High Capacity RNA-to-cDNA Master Mix (Applied BioSystems). Quantitative real-time PCR was performed for all the samples in the 2-week study and early time course study using Taqman Technologies) . Each sample was analyzed in triplicate with control samples used to calculate relative quantity (fold change) using the ∆∆C t method. The amount of starting cDNA was 10 ng of reverse transcribed cDNA (as total input RNA).
Transcription levels of Myo1E were measured in the 2-week study and early time course study. In the early time course study, cDNA samples in the 2-week study were also included to compare the expression changes between 2-week and early time points. Since there were no statistically significant differences between 2-week and early time course study control groups (data not shown), all the vehicle control groups in the 2-week study and at 8, 16, and 72 h in the early time course study were combined into one control group to calculate relative RNA quantities.
Protein isolation, SDS-PAGE and Western blotting.
Fresh frozen liver samples (N = 6 in the vehicle control group and N = 3 in the NTS-1 and TS-2 groups) in the 2-week study were fractionated with Sub-cellular Proteome Extraction Kit (EMD Biosciences) according to the manufacturer's protocol for tissues. Cytoplasmic protein samples were resolved on NuPAGE Novex 4-12% Bis-Tris Gel (Life Technologies). The resolved proteins were transferred onto nitrocellulose membranes with 0.2 µm pore size (Life Technologies). Membranes were blocked with SuperBlock T20 [Tris Buffered Saline (TBS)] Blocking Buffer (Thermo Scientific) for 30 min, incubated overnight at 4°C with 1 µg/ml goat anti-clathrin heavy chain antibody (sc-6579, Santa Cruz), 1 µg/ml rabbit anti-human dynamin antibody (sc-11362, Santa Cruz), 1 µg/ml goat anti-human AP2A2 antibody (sc-6422, Santa Cruz), or 2 µg/ml rabbit anti-AP2M1 antibody (S2509, Epitomics) diluted in SuperBlock and then washed in 0.1% Tween-20 in 1×TBS (TBST). Membranes were incubated for 1 h at room temperature with 0.08 μg/ml donkey anti-goat IgG antibody (sc-2020, Santa Cruz, used for clathrin and AP2A2) or 0.1 μg/ml goat anti-rabbit IgG antibody (474-1506, KPL, used for dynamin and AP2M1) diluted in TBST. After washing membranes with 0.1% Tween-20 in 1×PBS and PBS, they were incubated in SuperSignal West Dura Chemiluminescent Substrate (Thermo Scientific) and scanned by Typhoon 9400 (GE Healthcare) to visualize the protein bands. The band intensity was normalized using an endogenous control protein GAPDH to calculate relative expression levels.
Immunohistochemistry. Immunohistochemistry was performed on paraffin embedded liver sections from the 2-week and early time course studies. Primary and secondary antibodies (including clone and supplier), negative antibody controls, reagents for antigen retrieval and protein block, and antibody diluents used in the study are summarized in Supplementary Table 1. Caveolin and early endosome antigen 1 (EEA1) immunostaining was performed on a Discovery XT Autostainer (Ventana Medical Systems) while staining for clathrin and lysosomal-associated membrane protein 1 (LAMP1) was performed manually.
Blast analysis. To understand the presence of possible off-target genes of LNA gapmers (NTS-1, TS-2, and HTS-3), parent sequence for each LNA gapmer was uploaded to the Basic Local Alignment Search Tool (BLAST, http:// blast.ncbi.nlm.nih.gov/Blast.cgi) to identify possible sequence homologies to mouse protein-coding genes (cDNAs).
Statistical analysis. All statistical analyses were performed by GraphPad Prism 5 (GraphPad Software). Comparison of parameters for clinical chemistry and mRNA relative expression levels (Taqman PCR) between the LNA gapmers groups and the vehicle control group was performed using one way analysis of variance followed by Dunnett's test. Comparison of relative protein expression levels (Western blotting) in the LNA gapmers groups with the vehicle control group was performed using the unpaired t-test. A probability of error less than 5% was considered as significant.
RESuLTS

LNA Gapmer-Induced Hepatotoxicity in the 2-Week Study
Representative hematoxylin-eosin stained liver sections from mice administered NTS-1 and TS-2 for 2 weeks are shown in Figure 1 . In the TS-2-administered mice, hepatic changes were characterized by necrosis of hepatocytes and mixed cell infiltrates primarily around the central vein (Fig. 1A) . Centrilobular hepatocyte hypertrophy (data not shown), increased mitoses (data not shown), and single cell necrosis or apoptosis (Fig. 1A, insert) were also present in mice administered TS-2. The serum ALT (79-fold), AST (10-fold), ALP (1.9-fold), and GLDH (26-fold) levels were increased only in the TS-2 group (Fig. 1C) . Among 5 mice administered TS-2, FIg. 1. A, Liver section from a mouse administered toxic LNA gapmer TS-2. B, Liver section from a mouse administered non-toxic LNA gapmer NTS-1. C, serum ALT, AST, ALP, and GLDH levels of the vehicle, NTS-1, and TS-2 groups in the 2-week study. In the TS-2-administered mice (A), hepatic changes were characterized by centrilobular hepatocellular necrosis (including single cell necrosis/apoptosis [insert] ) that was associated with mixed inflammatory cell infiltration (arrows). In contrast, similar hepatocellular changes were not noted in mice administered NTS-1 (B). The serum ALT (79-fold), AST (10-fold), ALP (1.9-fold), and GLDH (26-fold) levels were increased only in the TS-2 group (C). *p < .05 compared to the vehicle group. Bar indicates SE. Original magnification: ×20. CV, central vein.
3 mice had elevated ALT levels (217, 660, and 15863 U/L) and associated histopathology changes (Fig. 1A) . In contrast, no microscopic liver changes or effects on clinical chemistry parameters were observed in mice administered NTS-1 (Figs. 1B and 1C).
Liver Gene Expression Analysis in the 2-Week Study
Microarray analysis was performed with liver RNA extracted from vehicle, NTS-1, and TS-2-administered mice. Genes were subjected to principal component analysis (PCA). Gene expression of mice receiving a toxic LNA gapmer TS-2 differed from vehicle and NTS-1-administered mice ( Fig. 2A) . Using the threshold criteria of adjusted p-value <.05 and absolute fold change >2 in expression compared with the vehicle group, 1315 genes were identified as DEGs in the TS-2 group whereas there were only 35 DEGs in the NTS-1 group (Table 1) . These genes were analyzed using CRE and IPA, and relevant gene networks and pathways were identified (Table 1) . CRE analysis generated statistically significant explanations (increased inflammatory responses, liver neoplasms, hypoxia, and oxidative stress) that were consistent with the hepatocellular single cell necrosis/apoptosis and surrounding inflammatory infiltrate and increased mitotic figures observed in the TS-2 group. IPA analysis identified 312 and 296 genes associated with cell death and cellular growth and proliferation, respectively. It also showed that TS-2 altered expression levels of many genes associated with hepatotoxicity (hepatocellular carcinoma, liver hyperplasia/hyperproliferation, liver steatosis, liver necrosis/ cell death, liver damage).
Changes in Clathrin-Mediated Endocytosis Signaling Genes in the 2-Week Study
IPA also revealed that a toxic LNA gapmer TS-2 altered expression levels of 17 genes involved in clathrin-mediated endocytosis (CME) signaling (Tables 1 and 2 ). Several chemicals, such as ethanol, are known to impair CME resulting in hepatotoxicity (Fernandez et al., 2009) . Quantitative realtime PCR was used to confirm microarray results for Myo1E, AP2A2, AP2M1, clathrin, and dynamin binding proteins (DNMBP) in the vehicle, NTS-1, and TS-2 groups. These genes were selected because they are involved in the formation of the clathrin-coated pit and its scission from the plasma membrane (Cheng et al., 2012; McMahon and Boucrot, 2011; Ungewickell and Hinrichsen, 2007) , and among these genes, Myo1E was the only gene significantly changed by TS-2 ( Table 2 ). The failure of scission of clathrin-coated pits from the plasma membrane due to Myo1E down-regulation might be one of the mechanisms involved in TS-2-mediated hepatotoxicity.
The quantitative real-time PCR results confirmed significant down-regulation of Myo1E (26-fold) in mice administered toxic LNA gapmer TS-2 but not in mice receiving a non-toxic LNA gapmer NTS-1 (1.5-fold) (Fig. 2B) . Although the expression levels of AP2A2, AP2M1, clathrin, and DNMBP were slightly increased following administration of NTS-1 (1.5-, 1.8-, 1.4-, and 1.4-fold, respectively) and TS-2 (1.7, 2.3, 1.6, and 1.9-fold, respectively) compared with the vehicle group (Fig. 2B) , these changes were minor. We also measured relative protein expression levels of a subset of CME signalingrelated proteins (AP2A2, AP2M1, clathrin, and dynamin) in selected liver lysate samples by using Western blotting. Myo1E expression was not assessed due to the lack of a suitable commercially available antibody. Normalized dynamin expression levels were significantly increased (2.4-fold) in the TS-2 group but not in the NTS-1 group (Fig. 2C) . No significant changes were observed in protein expression levels of AP2A2, AP2M1, and clathrin in either the NTS-1 or TS-2 groups (Fig. 2C) .
Distribution of Endocytosis-Related Proteins in Hepatocytes After 2-Week Administration
Due to the significant down-regulation of Myo1E expression observed in the TS-2 group, we hypothesized that TS-2 impaired the endocytic processes. It is well-known that internalized clathrin-coated vesicles are trafficked into endosomes, where they are sorted either back to the surface of the cell or into other compartments (i.e., lysosomes) for degradation (McMahon and Boucrot, 2011) . Therefore we examined the distribution of clathrin as a marker for clathrin-coated pits and vesicles, early endosome antigen 1 (EEA1) as a marker for endosomes, and lysosomal-associated membrane protein 1 (LAMP1) as a maker for lysosomes in liver sections by immunohistochemistry. In addition, the immunostaining for caveolin was investigated to understand the effect of LNA gapmers on caveolin-mediated endocytosis signaling.
Clathrin staining was observed in the perinuclear area of some hepatocytes, endothelium of small and large vessels, and Kupffer cells in the vehicle (Fig. 3A) and NTS-1 (data not shown) groups. In the TS-2 group, clathrin staining in the perinuclear area was increased, whereas sinusoid staining was decreased (Fig. 3B) . Granular staining of EEA1 and LAMP1 was observed in perinuclear areas and along the membrane of hepatocytes in the vehicle (Figs. 3C and 3E ) and NTS-1 (data not shown) groups. Similar to the changes in clathrin, EEA1 (Fig. 3D) and LAMP1 (Fig. 3F ) perinuclear staining was increased while the membrane staining was decreased in the TS-2 group compared to vehicle or NTS-1 groups. No differences were observed in the staining pattern of caveolin in the NTS-1 and TS-2 groups compared to the vehicle group (data not shown).
Minor Hepatic Hypertrophy Was the Only Change Observed After a Single Administration of LNA Gapmers
It was possible that the effect of TS-2 on the endocytic process was secondary to direct hepatic damage. To clarify the earliest transcriptional changes associated with LNA gapmer-induced hepatotoxicity and to understand whether the primary target for TS-2 is to disrupt the endocytic process, a second microarray analysis study was performed to analyze liver gene expression changes at early time points (8, 16 , and 72 h) after a single administration of FIg. 2 . A, PCA plot of gene expression from mice administered vehicle, non-toxic NTS-1, and toxic TS-2 for 2 weeks. B, Relative mRNA expression levels of Myo1E, clathrin, AP2A2, AP2M1, and dynamin binding protein (DNMBP) of the vehicle, non-toxic NTS-1, and toxic TS-2 groups in the 2-week study. C, Relative protein expression levels of clathrin, AP2A2, AP2M1, and dynamin of the vehicle, non-toxic NTS-1 and toxic TS-2 groups in the 2-week study. Gene expression of mice administered toxic LNA gapmer TS-2 differed from vehicle and a non-toxic LNA gapmer NTS-1-administered mice at 2 weeks (A). Significant down-regulation of Myo1E (−26-fold) was observed in mice receiving a toxic LNA gapmer TS-2 but not non-toxic LNA gapmer NTS-1 (1.5-fold). The mRNA expression levels of clathrin, AP2A2, AP2M1 and DNMBP showed only minor changes by the dosing of either NTS-1 or TS-2 compared with the vehicle group (B). Protein expression levels of dynamin were significantly increased (2.4-fold) in the toxic TS-2 group but not in the non-toxic NTS-1 group (C). No significant changes were observed in protein expression levels of clathrin, AP2A2, and AP2M1 either in the NTS-1 or TS-2 group (C). Myo1E expression could not be assessed due to the lack of suitable commercially available antibody. Detection of clathrin and AP2A2 was not successful in some vehicle controls due to technical difficulties (C). Both mRNA and protein expression levels were normalized using HRPT1 and GAPDH, respectively. *p < .05, **p < .01, and ***p < .001 compared to the vehicle group. LNA gapmers. In this time course study, an additional, more toxic LNA gapmer, HTS-3 was included in order to evaluate whether 2 different LNA gapmers share common mechanisms (transcription profiles) associated with hepatotoxicity.
Although samples were collected at 8 h and 16 h, because HTS-3 was highly toxic, the remaining mice were found dead or sacrificed due to moribund condition on day 3 (at least 48 h post administration); consequently, blood and liver samples were not No hypotheses associated with hepatotoxicity were generated by CRE.
240
collected at 72 h in this group. In contrast to the 2-week study, the only morphologic change was minor hepatic hypertrophy in all LNA groups across time points and there were no differences noted in any of clinical chemistry parameters (data not shown).
Liver Gene Expression Analysis in the Early Time Course Study
The PCA analysis of transcription profiling data at early time points is shown in Fig. 4A . The gene expression profile of the most toxic LNA gapmer HTS-3 differs from vehicle, NTS-1, and TS-2-groups at 16 h while the gene expression patterns for the NTS-1 and TS-2 groups were similar to each other across the time points. Interestingly, the gene expression profile at 8 h was similar for all LNA gapmers, including HTS-3. In this study, to determine DEGs, the threshold of p-value <.05 and absolute fold change >1.3 compared to the vehicle group was used to identify minor changes in the expression profile. DEGs in the NTS-1, TS-2, and HTS-3 groups at each time point were analyzed using CRE and IPA and summarized in Table 3 .
In the NTS-1 group, there were 133, 29, and 0 DEGs at 8, 16, and 72 h, respectively. CRE analysis revealed increased inflammatory responses at 8 and 16 h. The top canonical biological
FIg. 3. Immunostaining for clathrin (A and B), EEA1 (C and D)
, and LAMP1 (E and F) of the vehicle (A, C, and E) and toxic TS-2 (B, D, and F) groups in the 2-week study. Clathrin staining was observed in the perinuclear area of some hepatocytes, endothelium of small and large vessels, and Kupffer cells in the vehicle (A) and non-toxic NTS-1 groups (data not shown). In the TS-2 group, clathrin staining in the perinuclear area was increased, whereas sinusoid staining was decreased. Clathrin staining was also noted in the perinuclear area of inflammatory infiltrates in TS-2 group (B). Granule staining was observed in perinuclear area and along the membrane of hepatocytes for EEA1 and LAMP1 in the vehicle (C and E) and non-toxic NTS-1 (data not shown) groups. Similar to the changes in clathrin staining pattern, EEA1 (D) and LAMP1 (F) staining in the perinuclear area was increased in the toxic TS-2 group. Overall, the membrane staining for clathrin, EEA1 and LAMP1 was decreased in the toxic TS-2 group compared to vehicle or non-toxic NTS-1 groups. Original magnification was 20×. CV, central vein.
pathways that were significantly perturbed by NTS-1 at 8 and 16 h identified by IPA were pattern recognition receptors, interferon response, infectious disease, and inflammatory disease. These increased inflammatory responses were not observed in either the TS-2 or HTS-3 group at any time points. Changes in some genes associated with hepatotoxicity were observed at 8 h in the NTS-1 group, but not at 16 h. The number of DEGs for TS-2 was reduced compared to the HTS-3 group across the time points and even the NTS-1 group at 8 and 16 h. However, mRNA expression of Myo1E, that was significantly decreased in the TS-2 group after 2-week administration (Fig. 2B and Table 2) , was reduced at all time points, including 8 and 16 h when changes in genes associated with hepatotoxicity were not observed. In the HTS-3 group, CRE identified similar gene expression profiles to that induced by camptothecin (at 8 and 16 h) and topotecan (at 16 h). IPA identified that many DEGs at 8 and 16 h in the HTS-3 group were associated with DNA replication, recombination, and repair; cell cycle; cell death; and cell growth and proliferation. Although expression of only a few genes associated with hepatotoxicity were altered at 8h, additional genes associated with hepatotoxicity (liver hepatitis, liver proliferation, liver steatosis, liver damage, liver dysplasia) were perturbed at 16 h. IPA also identified 14 genes in mice administered HTS-3 at 16 h, but not 8 h, which were involved in FIg. 4 . A, PCA plot of gene expression from mice administered vehicle, non-toxic NTS-1, toxic TS-2, and severely toxic HTS-3 at 8, 16, and 72 h after a single injection. B, Relative mRNA expression levels of Myo1E of the vehicle (combined 2-week study and all time points in the early time course study), nontoxic NTS-1, and toxic TS-2 groups in the 2-week study and the early time course study (8, 16 , and 72 h after a single injection). The gene expression profile at 8 h was similar for all LNA gapmers, including the most toxic LNA gapmer HTS-3, whereas, at 16 h, gene expression profile of HTS-3 differs from vehicle, non-toxic NTS-1, and toxic TS-2-groups (A). The gene expression patterns for the non-toxic NTS-1 and toxic TS-2 groups were similar to each other across the time points (A). Transcriptional levels of Myo1E were significantly down-regulated in the toxic TS-2 group at 16 h (−2.9-fold), 72 h (−15-fold) in addition at 2 weeks (−22-fold) (B). Although a statistical significance was not observed in the toxic TS-2 group at 8 h, the relative expression level was reduced approximately 50% (B) . No changes in Myo1E levels were observed with the non-toxic NTS-1 and the most toxic HTS-3 groups at time points examined in the early time course study (B). mRNA expression levels were normalized using HRPT1. *p < .05 and ***p < .001 compared to the vehicle group. No hypotheses and gene networking associated with hepatotoxicity were generated by CRE and IPA, respectively. TAbLE 3-Continued CME signaling. Changes in the Myo1E expression levels were unique to the TS-2 group and were not observed in the HTS-3 group at 8 or 16 h (the only time points examined).
Changes in Myo1E Expression Levels and Distribution of Endocytosis-Related Proteins in the Early Time Course Study
Changes in Myo1E expression levels in the early time course study were confirmed using quantitative real-time PCR and compared to the 2-week study (Fig. 4B ). In the TS-2 group, transcriptional levels of Myo1E were significantly down-regulated at 16 (−2.9-fold), 72 (−15-fold) h, and 2 weeks (−22-fold). Although a statistical significance was not observed at 8 h, the relative expression level was reduced approximately 50%. No changes in Myo1E levels were observed with the NTS-1 and HTS-3 groups at time points examined in the early time course study.
To further investigate the effects of NTS-1, TS-2, and HTS-3 on the endocytic processes, we examined the distribution of caveolin, clathrin, EEA1, and LAMP1 using immunohistochemistry. No significant changes in any of the staining patterns were observed in NTS-1, TS-2, and HTS-3 groups at time points examined in the early time course study.
Blast Analysis of 3 LNA Gapmer Sequences to Identify the Possible Target Genes in Mice and Evaluation of Their Expression Changes in the 2-Week and Early Time Point Studies
Even though the sequences used for LNA gapmers did not target any specific genes in mice, it is possible that partial sequence identity may cause non-specific gene expression changes. Therefore, we used Blast (http://blast.ncbi.nlm. nih.gov/) to identify mouse genes with complete or partial sequence homology to the parent sequence of LNA gapmers (NTS-1, TS-2, and HTS-3) and investigated if their transcription changes were represented in the microarray data.
The non-toxic LNA gapmer NTS-1 did not have a perfect match to any Mus musculus genes. However, it has a partial sequence homology to Acyl-CoA synthetase long-chain family member 6 (Acslc6) gene with 2 mismatches (data not shown). The microarray data revealed no changes in transcription levels of Acslc6 in mouse liver after dosing of NTS-1 in either the 2-week or early time course study (data not shown).
TS-2 does not have a perfect match to any Mus musculus genes but has a single mismatch with 3 genes and 2 mismatches with 6 genes (data not shown). Among the genes with partial sequence homologies, expression levels of Zinc finger protein 191 in the 2-week study and at 16 and 72 h in the early time course study and RIKEN cDNA 9030624J02 gene in the 2-week study were decreased in mouse liver after administration of TS-2 (Table 4 ). There are 3 Mus musculus genes with complete sequence homology, 10 genes with a single mismatch, and 22 genes with 2 mismatch oligonucleotides for the most toxic LNA gapmer HTS-3 (data not shown). 
DISCuSSION
The present study demonstrated that different LNA gapmers modulate distinct transcriptional pathways and ultimately result in hepatotoxicity in mice. Disruption of the clathrin-mediated endocytic process may be an initiating event for a toxic LNA gapmer TS-2 while the most toxic LNA gapmer HTS-3 appears to perturb pathways associated with DNA damage. It was demonstrated that different LNA sequences showed similar biodistribution and accumulation in tissues (i.e., liver) (Straarup et al., 2010 and unpublished Pfizer results) . Therefore, although the absolute concentrations of LNA gapmers in liver were not determined in the present study, we did not consider differences in liver exposure as the cause of distinct transcription profiles of NTS-1, TS-2, and HTS-3.
Following the 2-week administration, histopathological changes such as increased hepatocellular necrosis (including centrilobular hepatocyte necrosis and single cell necrosis/ apoptosis), inflammatory cell infiltration and mitotic figures, and elevated levels of serum ALT, AST, ALP, and GLDH were observed in the mice receiving a toxic LNA gapmer TS-2. CRE and IPA also identified hepatic gene expression patterns consistent with hepatotoxicity in this group. In contrast, similar changes were not identified in the non-toxic LNA gapmer (NTS-1) group. In the early time course study, the third LNA gapmer HTS-3 was demonstrated to be more toxic than TS-2 since it was lethal on day 3. There were no changes in clinical chemistry or histopathological findings indicating that liver injury was not observed in the HTS-3 group at 8 and 16 h after a single administration. This was not surprising since clinical chemistry and histopathological changes indicating liver injury are rarely observed <24 h after administration of test articles. Indeed, in a previous toxicity study using mice administered HTS-3, severe centrilobular necrosis was noted where histopathology samples were obtained >24 h after a single administration, and therefore liver toxicity was identified as the most likely cause of animal death (unpublished Pfizer results).
In higher eukaryotic cells, clathrin-dependent endocytosis is the important pathway for the uptake of macromolecules (Conner and Schmid, 2003; Le Roy and Wrana, 2005; McMahon and Boucrot, 2011; Ungewickell and Hinrichsen, 2007) . Several chemicals have been shown to impair clathrinmediated endocytosis (CME) and resulting in hepatotoxicity. For example, ethanol altered the clathrin-mediated internalization of asialoglycoprotein receptor (ASGP-R), resulting in impaired ASGP-R-mediated uptake of alcohol-damaged apoptotic cells (Casey et al., 2008; Fernandez et al., 2009 ). This may result in accumulation of apoptotic bodies and inflammation in liver, leading to Kupffer cell activation followed by hepatocyte apoptosis (Casey et al., 2008) . In the 2-week study, microarray data demonstrated that 17 genes associated with CME signaling were significantly perturbed in mice administered TS-2 (Table 2) . Quantitative real-time PCR confirmed that expression levels of Myo1E were significantly decreased (−26-fold, Fig. 2B ) in the TS-2 group. Due to the lack of specific antibodies to detect mouse Myo1E by Western blotting or immunoprecipitation, mRNA and protein expression of Myo1E in the TS-2 group could not be correlated. However, protein levels of dynamin were significantly increased (2.4-fold, Fig. 2C ) in the TS-2 group. This may be a compensatory response to significant down-regulation of Myo1E. In addition, the membrane distribution of clathrin, early endosome (EEA1), and lysosome (LAMP1) in hepatocytes was significantly altered in mice receiving TS-2 (Fig. 3) 
TAbLE 4
Sequence Homology of LNA gapmers to Mouse genes and Expression Changes of Possible Off-Target genes Identified by bLAST Analysis after the 2-week administration. Considering that we did not detect changes in clathrin and adaptor proteins (AP2A2 and AP2M1) expression levels by Western blotting, TS-2 might change only the distribution but not protein levels associated with CME pathway. Transport and distribution of vesicles (i.e., clathrin-coated pit/vesicle) and organelles (i.e., endosomes and lysosomes) within the cell are controlled by cytoskeletal filaments (Mundy et al., 2002) . Therefore, the changes observed in the immunostaining of clathrin, EEA1, and LAMP1 might be due to a disruption in the cytoskeleton filaments, such as actin and microtubules, which are affecting distribution of clathrin-coated vesicles, endosomes, and lysosomes. These changes may indicate that TS-2 caused the interruption of cargo delivery to lysosomes for degradation. Degradation within lysosomes is a vital catabolic process that degrades cytoplasmic components known as autophagy (Murrow and Debnath, 2013) . This provides cytoprotective response to pathologic stresses and quality-control function in the cell by promoting basal turnover of long-lived proteins and organelles, as well as by selectively degrading damaged cellular components (Murrow and Debnath, 2013) . Changes on these functions might be involved in the mechanism of TS-2-induced hepatotoxicity in mice. Considering that no changes were observed for clathrin, EEA1, and LAMP1 staining at 8, 16, and 72 h after a single administration, multiple administration of TS-2 might be required to induce disruption of endocytic process. At least up to 16 h, HTS-3 did not affect distribution of clathrin, EEA1, and LAMP1.
Microarray data in the early time course study demonstrated Myo1E down-regulation at 8, 16, and 72 h after a single injection of TS-2 although many other CME signaling-related factors did not change at these time points. These results indicate that TS-2 directly reduce Myo1E expression levels, resulting in impaired CME, that may have contributed to hepatotoxicity. It is important to note that TS-2 has no sequence homology to mouse Myo1E gene according to the BLAST analysis and is not considered to be the target gene for TS-2 (Table 4) . Unlike TS-2, CRE analysis demonstrated that the severely toxic HTS-3 at 8 and 16 h shared similar transcription changes to that of camptothecin and topotecan, both selective inhibitors of topoisomerase I (TOP1), an enzyme necessary for DNA replication (Hsiang and Liu, 1988; Kollmannsberger et al., 1999) . These TOP1 inhibitors trap the TOP1 cleavage complex by inhibiting religation, and TOP1 cleavage complex can be converted to irreversible DNA damage, resulting in cell death (Pommier, 2006; Pommier et al., 2006) . In this study, IPA supported the hypothesis generated by CRE, identifying many gene and pathway changes at 8 and 16 h associated with DNA replication, recombination, and repair; cell cycle; cell death; and cell growth and proliferation. However, it is possible that the causal gene expression changes in the HTS-3 group occurred at <8 h, and these DNA-damage responses may be secondary. Additional transcription analysis at earlier time points (<8 h after administration) will help to identify the initiating mechanisms. The IPA results showed that HTS-3 perturbed 14 genes involved in the CME pathway at 16 h but not at 8 h. The expression levels of Myo1E were not changed in the HTS-3 groups at 8 and 16 h. These results suggest that transcription changes associated with DNA damage precede the transcription changes associated with CME signaling pathway in mice administered HTS-3. Therefore, the effect on the endocytosis pathway may be a secondary effect of HTS-3-mediated DNA damage leading to cell death.
CRE analysis of the non-toxic NTS-1 identified DEGs associated with increased inflammatory response pathways at 8 and 16 h, but not at 72 h. IPA identified DEGs associated with pattern recognition receptors, inflammatory response, and infectious disease and inflammatory disease signaling at 8 and 16 h, but not at 72 h. It was surprising to observe gene expression changes associated with inflammatory responses since, unlike 2'-MOE and earlier generation ASOs, hepatic inflammation is not commonly observed with LNA gapmers, unless accompanied by necrosis (Burel et al., 2012; Burdick, Sciabola, Mantena, Hollingshead, Stanton, Warneke, Zeng, Martsen, Medvedev, Makarov, Reed, Davis II, and Whiteley) . In spite of these altered gene expression patterns with NTS-1 administration, no histopathological evidence of inflammation was observed in the 2-week and the early time course studies, or the studies of longer duration (unpublished Pfizer data), and NTS-1 was well tolerated in mice. Similar gene expression changes were not observed either in the TS-2 or HTS-3 group in the early time course study.
BLAST analysis indicated the possibility that additional mouse genes could be modulated if complete or partial sequence homology to non-target gene sequences was present. We could not determine whether this modulation was due to LNA gapmers binding to these genes or effects downstream of LNA gapmer-induced hepatotoxicity. Importantly, Myo1E down-regulation in the TS-2 group and activation of DNA damage pathway in the HTS-3 group occurred at 8 h prior to the expression changes of the possible off-target genes with partial sequence homology observed at 16 h. There were no common genes with 0, 1, or 2 sequence mismatches for hepatotoxic TS-2 and HTS-3. Considering that HTS-3 showed stronger modulation of these non-target genes than TS-2 at 16 h, possible off-target effects might be related to the magnitude of LNAinduced toxicity.
In summary, transcription profiling analysis using one non-toxic LNA gapmer and two toxic LNA gapmers suggested that these two toxic sequences are likely to modulate distinct transcriptional pathways in mice leading to hepatotoxicity with no apparent overlap of transcription and pathway changes. Disruption of the CME pathway and endocytic process may be an initiating event for TS-2-induced hepatotoxicity in mice. Transcription changes associated with DNA damage may precede the transcription changes associated with endocytosis pathways in mice administered HTS-3. Further studies using a variety of sequences are required to understand if variations in the LNA gapmer sequence modulate distinct transcriptional changes and toxicity profiles in mice and if there are any apparent common pathways leading to hepatotoxicity.
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